Myriad Genetics buy DerAlmanach100000
Start price
03.06.25
/
50%
€4.34
Target price
03.07.25
-
Performance (%)
8.29%
End price
04.06.25
€4.70
Summary
This prediction ended on 04.06.25 with a price of €4.70. The BUY prediction by DerAlmanach100000 finished with a performance of 8.29%. DerAlmanach100000 has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. DerAlmanach100000 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -2.500% | -2.500% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
According to DerAlmanach100000 what are the pros and cons of Myriad Genetics for the foreseeable future?
Pros
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
Very Future proof/growth oriented business model
Market Leader or Top 3
Cons
Comments by DerAlmanach100000 for this prediction
In the thread Trading Myriad Genetics
Current prediction by DerAlmanach100000 for Myriad Genetics
Myriad Genetics
Start price
Target price
Perf. (%)
€6.30
23.11.25
23.11.25
-
23.11.28
23.11.28
-7.14%
18.12.25
18.12.25
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Undervalued
